AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Rowan, K
Citation: K. Rowan, The development and validation of a multi-dimensional measure of chronic foot pain: The ROwan Foot Pain Assessment Questionnaire (ROFPAQ), FOOT ANKL I, 22(10), 2001, pp. 795-809

Authors: Tilley, JW Kaplan, G Rowan, K Schwinge, V Wolitzky, B
Citation: Jw. Tilley et al., Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists, BIOORG MED, 11(1), 2001, pp. 1-4

Authors: Padkin, A Rowan, K Black, N
Citation: A. Padkin et al., Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C, BR MED J, 323(7318), 2001, pp. 923-926

Authors: Sidduri, A Lou, JP Campbell, R Rowan, K Tilley, JW
Citation: A. Sidduri et al., Synthesis of constrained L-phenylalanine derivatives incorporating a benzazepinone or an azepinone ring as VCAM/VLA-4 antagonists, TETRAHEDR L, 42(50), 2001, pp. 8757-8760

Authors: Young, JD Goldfrad, C Rowan, K
Citation: Jd. Young et al., Development and testing of a hierarchical method to code the reason for admission to intensive care units: the ICNARC Coding Method, BR J ANAEST, 87(4), 2001, pp. 543-548

Authors: Chen, L Tilley, JW Huang, TN Miklowski, D Trilles, R Guthrie, RW Luk, K Hanglow, A Rowan, K Schwinge, V Wolitzky, B
Citation: L. Chen et al., N-acyl phenylalanine analogues as potent small molecule VLA-4 antagonists, BIOORG MED, 10(8), 2000, pp. 725-727

Authors: Chen, L Tilley, JW Guthrie, RW Mennona, F Huang, TN Kaplan, G Trilles, R Miklowski, D Huby, N Schwinge, V Wolitzky, B Rowan, K
Citation: L. Chen et al., N-benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists, BIOORG MED, 10(8), 2000, pp. 729-733

Authors: Tilley, J Kaplan, G Fotouhi, N Wolitzky, B Rowan, K
Citation: J. Tilley et al., Carbacyclic peptide mimetics as VCAM-VLA-4 antagonists, BIOORG MED, 10(11), 2000, pp. 1163-1165

Authors: Fotouhi, N Joshi, P Tilley, JW Rowan, K Schwinge, V Wolitzky, B
Citation: N. Fotouhi et al., Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists, BIOORG MED, 10(11), 2000, pp. 1167-1169

Authors: Fotouhi, N Joshi, P Fry, D Cook, C Tilley, JW Kaplan, G Hanglow, A Rowan, K Schwinge, V Wolitzky, B
Citation: N. Fotouhi et al., The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic, BIOORG MED, 10(11), 2000, pp. 1171-1173

Authors: Vella, K Goldfrad, C Rowan, K Bion, J Black, N
Citation: K. Vella et al., Use of consensus development to establish national research priorities in critical care, BR MED J, 320(7240), 2000, pp. 976-980

Authors: Goldfrad, C Rowan, K
Citation: C. Goldfrad et K. Rowan, Consequences of discharges from intensive care at night, LANCET, 355(9210), 2000, pp. 1138-1142

Authors: Gunning, K Rowan, K
Citation: K. Gunning et K. Rowan, ABC of intensive care - Outcome data and scoring systems, BR MED J, 319(7204), 1999, pp. 241-244

Authors: Langham, J Thompson, E Rowan, K
Citation: J. Langham et al., Identification of randomized controlled trials from the emergency medicineliterature: Comparison of hand searching versus MEDLINE searching, ANN EMERG M, 34(1), 1999, pp. 25-34
Risultati: 1-14 |